Category Archives: new treatments

A role for vitamin D in the treatment of multiple sclerosis (MS)

This is such an important topic that I am posting the full-length article. On pubmed at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882221/?tool=pubmed. Neurology. 2010 June 8; 74(23): 1852–1859. doi:  10.1212/WNL.0b013e3181e1cec2 PMCID: PMC2882221 A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis … Continue reading

Posted in dietary, Health, metabolic, new treatments, Psychiatry/Neurology | Tagged , , , , |

The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults.

Nutr J. 2011 Oct 20;10:117. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. … Continue reading

Posted in Aging, Health, metabolic, new treatments | Tagged , , |
Maurice Preter, MD

Maurice Preter, MD is a European and U.S. educated psychiatrist, psychotherapist, psychopharmacologist, neurologist, and medical-legal expert in private practice in Manhattan. He is also the principal of Fifth Avenue Concierge Medicine, PLLC, a medical concierge service and health advisory for select individuals and families.